Kyung Dong Pharmaceutical Co (XKRX:011040) Scaled Net Operating Assets : 0.74 (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Kyung Dong Pharmaceutical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Kyung Dong Pharmaceutical Co's operating assets for the quarter that ended in Mar. 2024 was ₩262,540 Mil. Kyung Dong Pharmaceutical Co's operating liabilities for the quarter that ended in Mar. 2024 was ₩45,171 Mil. Kyung Dong Pharmaceutical Co's Total Assets for the quarter that ended in Dec. 2023 was ₩292,971 Mil. Therefore, Kyung Dong Pharmaceutical Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.74.

Kyung Dong Pharmaceutical Co Scaled Net Operating Assets Historical Data

The historical data trend for Kyung Dong Pharmaceutical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyung Dong Pharmaceutical Co Scaled Net Operating Assets Chart

Kyung Dong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.65

0.71

0.74

0.82

0.68

Kyung Dong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.70	0.75	0.75	0.74	0.74

Competitive Comparison of Kyung Dong Pharmaceutical Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Kyung Dong Pharmaceutical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kyung Dong Pharmaceutical Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyung Dong Pharmaceutical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Kyung Dong Pharmaceutical Co's Scaled Net Operating Assets falls into.

Kyung Dong Pharmaceutical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Kyung Dong Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(260896.238	-	49120.531)	/	310477.908
=	0.68

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	292970.765	-	32074.527
=	260896.238

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	64493.723	-	81.078	-	15292.114
=	49120.531

Kyung Dong Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(262539.867	-	45171.421)	/	292970.765
=	0.74

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	294348.572	-	31808.705
=	262539.867

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	78421.084	-	14.909	-	33234.754
=	45171.421

Kyung Dong Pharmaceutical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Kyung Dong Pharmaceutical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyung Dong Pharmaceutical Co (XKRX:011040) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyung Dong Pharmaceutical Co Ltd (XKRX:011040) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

N/A

Address

1926, Nambusunhwan-ro, Gwanak-gu, Seoul, KOR

Website

http://www.kdpharma.co.kr

Kyung Dong Pharmaceutical Co Ltd is a South Korea-based company engaged in the manufacturing and marketing of pharmaceutical products. Its products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases.

Kyung Dong Pharmaceutical Co (XKRX:011040) Headlines

No Headlines